Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

BACKGROUND: Growth impairment remains common in children with chronic kidney disease (CKD). Available literature indicates low level of recombinant human growth hormone (rhGH) utilization in short children with CKD. Despite efforts at consensus guidelines, lack of high-level evidence continues to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Akchurin, Oleh M., Kogon, Amy J., Kumar, Juhi, Sethna, Christine B., Hammad, Hoda T., Christos, Paul J., Mahan, John D., Greenbaum, Larry A., Woroniecki, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450116/
https://www.ncbi.nlm.nih.gov/pubmed/28558814
http://dx.doi.org/10.1186/s12882-017-0599-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450116/
https://www.ncbi.nlm.nih.gov/pubmed/28558814
http://dx.doi.org/10.1186/s12882-017-0599-1

Ejemplares similares